GlassScriptPhysician profile
Robert James Shields
NPI 1740668839
$3,631.10
in general payments reported to CMS, 2019-2025
29 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $244 · 2021: $575 · 2022: $1,540 · 2023: $182 · 2024: $344 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $1,342.87 | 2022-2024 | |
| Stryker Corporation | $827.89 | 2019-2023 | Prophecy, Easyfuse |
| Smith+Nephew, INC. | $267.55 | 2019-2021 | |
| Paragon 28, INC. | $160.36 | 2019-2024 | Gorilla |
| Horizon Therapeutics Plc | $133.42 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $127.34 | 2019-2025 | Nuzyra |
| Arthrex, INC. | $79.34 | 2022 | |
| Biotissue Holdings INC. | $77.25 | 2024-2025 | |
| Organogenesis INC. | $66.83 | 2022 | |
| Depuy Synthes Sales INC. | $58.26 | 2021 | |
| Kerecis Limited | $45.20 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $45.10 | 2024 | |
| Ibsa Pharma INC. | $42.13 | 2022-2023 | Tirosint, Licart |
| Nevro Corp. | $36.73 | 2023 | Senza |
| Aroa Biosurgery Incorporated | $35.38 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $30.89 | 2021-2022 | |
| Abbvie INC. | $28.99 | 2022-2023 | Dalvance |
| Innovation Technologies INC | $28.36 | 2024 | Irrisept |
| Bioventus LLC | $24.30 | 2023 | Stimrouter Implantable Kit |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.56 | 2021 | |
| Alfasigma USA, INC. | $20.35 | 2021 | |
| Solventum Corporation | $20.15 | 2025 | Activ.A.C. |
| Pacira Pharmaceuticals Incorporated | $18.88 | 2025 | Exparel |
| Tenex Health INC. | $18.05 | 2021 | |
| Boston Scientific Corporation | $16.34 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.85 | 2022 | |
| Kci USA, INC. | $13.50 | 2021 | |
| Convatec INC. | $13.44 | 2021 | |
| Grt US Holding, INC. | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.